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B lymphocyte hyperactivation and elevated immuno-
globulin levels (hypergammaglobulinemia) are path-
ogenic manifestations of HIV-1 infection. Here we
provide evidence that these hallmarks are caused
by a soluble factor whose production by infected
macrophages is induced by the HIV-1 Nef protein.
In vitro, HIV-1-infected macrophages or macro-
phages expressing Nef promoted B cell activation
and differentiation to immunoglobulin-secreting
cells. Nef-mediated activation of NF-kB in macro-
phages induced secretion of the acute-phase protein
ferritin, and ferritin was necessary and sufficient for
the observed Nef-dependent B cell changes. The ex-
tent of hypergammaglobulinemia in HIV-1-infected
individuals correlated directly with plasma ferritin
levels and with viral load. Furthermore, the induction
of ferritin production and hypergammaglobulinemia
was recapitulated when Nef was specifically ex-
pressed in macrophages and T cells of transgenic
mice. Collectively, these results indicate that the
HIV-1 Nef protein carries a pathogenic determinant
that governs B cell defects in HIV-1 infection.
INTRODUCTION
HIV infection causes a dramatic impairment of T cell-mediated
immunity as a consequence of the rapid turnover of CD4+ T
lymphocytes (Fauci, 1993). The humoral arm of the immune sys-
tem frequently sustains further damage, and B cells exhibit pro-
found functional deficiencies (Jacobson et al., 1991; Lane et al.,
1983). In HIV-infected patients, B lymphocyte responses to
T cell-independent and common-recall antigens are diminished
(De Milito et al., 2004b; Moir et al., 2001). Cells exhibit increased
surface expression of CD70 (De Milito et al., 2004b) and CD71
(Martinez-Maza et al., 1987), indicative of hyperactivation.
B cells also demonstrate a more differentiated phenotype as evi-
denced by higher levels of CD38 (Conge et al., 1998) and the
sustained expression of CD70 (De Milito, 2004a; Martinez-
Maza et al., 1987), which is accompanied by spontaneous immu-noglobulin secretion in vitro (Amadori et al., 1989; Moir et al.,
2001) and hypergammaglobulinemia in vivo (Abelian et al.,
2004; De Milito, 2004a; Lane et al., 1983). Infected individuals
have levels of plasma immunoglobulin up to twice that of normal
levels (Lane et al., 1983; Lucey et al., 1992), which is primarily
a result of polyclonal activation since plasma immunoglobulin
concentrations remain high, despite a decline in HIV-specific
responses as disease progresses (Amadori et al., 1989; Shirai
et al., 1992).
Several cofactors have been proposed as mediators of B cell
dysfunction in HIV-1 infection. HIV-1 virions or virion proteins,
such as the viral envelope glycoprotein gp120, have been shown
to impair B cell function in vitro (Pahwa et al., 1986; Patke and
Shearer, 2000). Cytokines induced as a result of perturbed sig-
naling during HIV infection also impact B cell activity in culture
(De Milito, 2004a). An array of principally proinflammatory medi-
ators—TNFa IL-6, IL-10, and IL-15—can account in part for
some aspects of B cell dysfunction. However, evidence that
these factors promote all facets of HIV-dependent B cell dys-
function in vitro is incomplete, and their correlation to patient
data is poor (De Milito, 2004a; Kacani et al., 1997; Muller et al.,
1998; Patke and Shearer, 2000; Rautonen et al., 1991). Cytokine
production is significantly modified by the direct infection of per-
missive target cells with HIV. For example, in macrophages, viral
infection induces inflammatory chemokines and release of solu-
ble immunoregulatory surface antigens (Swingler et al., 2003,
1999). Chemokine production is regulated by the accessory pro-
tein Nef and involves signaling through the NF-kB cascade
(Swingler et al., 2003).
Here, we present evidence that HIV-1 Nef, through activation
of NF-kB, induces the secretion of ferritin from infected macro-
phages and that this causes B cell activation and hypergamma-
globulinemia. Our results reveal the presence of an inherent
pathogenicity determinant in HIV-1 Nef that is responsible for
B cell defects, which are a hallmark of HIV-1 infection.
RESULTS
HIV-1-Infected Macrophages Activate and Differentiate
B Lymphocytes In Trans
We previously demonstrated that soluble factors induced from
infected macrophages by Nef facilitated the ability of resting
CD4+ T lymphocytes to support HIV-1 replication (SwinglerCell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 63
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Nef-Induced B Cell Dysfunction in HIV InfectionFigure 1. Supernatants fromHIV-1-InfectedMacrophagesandMacrophagesExpressingHIV-1Nef InduceBCell Proliferation,Differentiation,
and Immunoglobulin Production
(A) Induction of B cell proliferation by HIV-1 Nef-expressing macrophage supernatants. Supernatants from macrophages 16 hr postinfection with recombinant
adenovirus expressing HIV-1 Nef or GFP (Swingler et al., 1999) or mock infectedwere incubatedwith peripheral blood lymphocytes (left panel) and purified B cells64 Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc.
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that peripheral blood lymphocytes (PBLs) proliferated when ex-
posed to supernatants frommacrophages expressing HIV-1 Nef
(Figure 1A). Nef-expressing macrophage supernatants selec-
tively induced the proliferation of B cells but not of T cells
(Figure 1A), while supernatants from GFP-expressing macro-
phages or mock-infected macrophages did not cause the prolif-
eration of either lymphocyte subset (Figure 1A). B lymphocytes
undergo a pattern of differentiation in the transition from a resting
state to antibody-producing plasma cells. This is characterized
by the time-dependent upregulation of activation molecules,
such as CD38, and ultimately the expression of syndecan-1
(CD138), which is a proteoglycan indicative of plasma cells
(Jego et al., 1999). Following exposure of B cells to supernatants
from Nef-expressing macrophages, but not macrophages ex-
pressing a control protein (GFP) or untreated macrophages
(mock), there was an increase in the percentage of B cells ex-
pressing CD38 and CD70 (Figure 1B). These effects were also
elicited by Nef when expressed in the context of HIV-1 infection
(Figure 1C). Thus, supernatants of wild-type HIV-1-infected
macrophages, but not DNef HIV-1-infected macrophages ob-
tained at the peak of viral replication, caused a similar change
in activation in differentiation status as evidenced by CD38
expression (Figure 1C). FACS analysis of CD38+-gated cells for
sIgM and CD138 expression demonstrated that B cells exposed
to Nef-expressing macrophages or wild-type HIV-1-infected
macrophages exhibited increased surface IgM and CD138
expression (Figure 1D). The B cell effects promoted by Nef-
expressing macrophage supernatants or by supernatants from
wild-type HIV-1-infected macrophages were comparable in
magnitude to those induced by a classical B cell differentiation
stimulus (aIgD/IL-4/rCD40L) (Figure 1D). The secretion of immu-
noglobulin subtypes—IgA, IgG, and IgM—was also induced
relative to supernatants from macrophages expressing GFP
(Figure 1E) or macrophages infected with a Nef-deleted virus
(HIV-1DNef) and mock-infected macrophages (Figure 1F). Collec-
tively, these results suggest that Nef expression, or Nef in the
context of HIV-1 replication inmacrophages, leads to the release
of a soluble factor(s) that induces hyperactivation of resting
B cells and differentiation to antibody-secreting cells.
Ferritin Is Induced by HIV-1 Nef
In order to characterize the factors responsible for the B cell
effects, macrophages were cultured in serum-free medium and
infectedwith a GFP or Nef-expressing adenovirus vector. Super-
natants were harvested, passed through a series of definedmolecular weight cutoff filters, and assayed for ability to induce
B cell proliferation. This activity was specific to Nef-expressing
macrophage supernatants and was retained by 100 kD molecu-
lar weight cutoff filters (Figure 2A). In supernatants of Nef-
expressing macrophages relative to GFP-expressing macro-
phages, the molecular weight of the B cell stimulatory activity
was more precisely estimated by separation of concentrated su-
pernatants under nondenaturing polyacrylamide gel electropho-
resis and analyses of factors eluted from gel slices (data not
shown). When proteins were eluted from those regions and as-
sayed for the ability to induce B cell proliferation, the majority
of the proliferative activity resided in the region around 250K.
When a replicate gel was prepared under denaturing conditions,
several Nef-specific bands were evident in supernatants of Nef-
expressing macrophages relative to GFP-expressing macro-
phages, and these were subject to peptide microsequencing.
Multiple peptides from this high molecular weight species corre-
sponded exclusively to human ferritin, human ferritin light chain,
and human ferritin heavy chain (Figure 2B); accession numbers
0901237A, NP000137, PO2792, and AAH69538). The identity
of ferritin in macrophage supernatants was confirmed by the
use of reducing gels, western blotting, and comigration with re-
combinant heavy and light forms of ferritin (Figure 2B, lower
panel). Macrophages expressing Nef produced elevated levels
of ferritin relative to GFP-expressing macrophages or mock-
infected macrophages (Figure 2C), and there was a statistical
correlation between the presence of Nef and ferritin in eight
replicate experiments (p < 0.0001) (Figure 2D). We also exam-
ined ferritin induction in macrophages supporting a spreading
infection. We have previously demonstrated that wild-type and
Nef-deleted variants of HIV-1 replicate to similar extents in mac-
rophages (Swingler et al., 1999), and here it was also evident that
Nef was required for the induction of ferritin (Figure 2E). In mac-
rophages from five different donors, infection with macrophage-
tropic HIV-1 (HIV-1ADA) wild-type, but not Nef-deleted HIV-1ADA,
was necessary for the release of ferritin (p = 0.031) (Figure 2F).
Although ferritin was induced by HIV-1WT-infected macro-
phages, there was no induction of ferritin from HIV-1-infected T
lymphocytes purified from peripheral blood (Figure 2G). There-
fore, the induction of ferritin by HIV-1 was manifest specifically
in infected macrophages.
Ferritin Induction byHIV-1 Nef Involves NF-kBActivation
We have previously demonstrated that Nef regulates chemokine
production (MIP-1a and MIP-1b) by macrophages and that this
induction is NF-kB dependent (Swingler et al., 2003). Consistentor T cells (middle panels). Tritiated-thymidine incorporation was determined after 3 days, and 3H-thymidine incorporation by B cells treated with a potent differ-
entiation stimulus (aIgD/CD40L/IL-4) is shown for comparison (right panel) (*).
(B–D)Supernatants fromNef-expressingmacrophages andHIV-infectedmacrophagespromotedifferentiationofB lymphocytes, ultimately to plasma cells. Purified
Bcellswere incubatedwithNef-expressing (B)orHIV-1-infected (C)macrophagesupernatants.PercentpositiveCD19,CD38,andCD70cellsare shown inbarcharts
for (B) and (C) [**]. FACS analysis (D) of surface CD138 and sIgM antigens was performed on CD38+-gated B cells following exposure to supernatants from Nef-ex-
pressing macrophages (upper panels) and HIV-1-infectedmacrophage supernatants (lower panels). Percent-positive cells are shown in each quadrant of the scat-
terplots. CD138 and sIgM expression on CD38+-gated cells exposed to a control stimulus (aIgD/IL-4/rCD40L) is shown for comparison (right-hand panel) (**).
(E)Bcell culturesexposed tosupernatants frommacrophagesexpressingNef secrete immunoglobulins.PurifiedBcellswere treatedwithmacrophage supernatants
as in (A), and immunoglobulin levels in B cell supernatants were determined after 7 days.
(F) HIV-1WT-infectedmacrophages drive immunoglobulin production fromB cells. Supernatants fromHIV-1WT-infected, HIV-1DNef-infected, andmock-infected
macrophageswereharvestedat thepeakof viral replication, added topurifiedBcells as in (E), and immunoglobulin levels determinedafter 7days (*).Where indicated
by *, values represent mean ± SD of two independent experiments performed in duplicate. Where indicated by **, panels show representative data from two inde-
pendent experiments.Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 65
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Nef-Induced B Cell Dysfunction in HIV InfectionFigure 2. HIV-1 Nef Induces Ferritin Production by Macrophages but Not T Cells
(A) A high molecular weight factor in Nef-expressing macrophage supernatants induces B cell proliferation. Retentates (R) or filtrates (F)—obtained following
centrifugation of serum-free, Nef-expressing macrophage supernatants through various molecular weight cutoff filters—were added to purified B cells for anal-
ysis of proliferative activity (error bars, SD).
(B) Microsequencing of a high molecular weight species from nondenaturing gels of concentrated Nef-expressing macrophage supernatants identified ferritin
(upper panel). Accession numbers are 0901237A, NP000137, PO2792, and AAH69538. Nef-induced ferritin (lower panel) comprises of two subunits supernatants
that comigrate with FTL and FTH.
(C) Nef-dependent induction of ferritin release from macrophages. Ferritin concentrations are shown in supernatants of macrophages expressing HIV-1 Nef or
GFP and mock-infected macrophages.
(D) Statistical analysis of ferritin release from macrophage cultures expressing Nef, GFP, or mock (ANOVA; error bars, SEM).
(E) Macrophages replicating HIV-1 containing an intact nef gene produce ferritin. At various intervals postinfection, supernatants were harvested from HIV-1
WT-infected, HIV-1 DNef-infected, and mock-infected macrophage cultures and analyzed for viral reverse transcriptase activity (right-hand panel) and
ferritin (left-hand panel).
(F) Statistical analysis of peak ferritin release from macrophage cultures infected with HIV-1 WT, HIV-1 DNef, or mock (ANOVA; error bars, SEM).
(G) CD4+ T lymphocytes do not produce ferritin in response to HIV-1 infection. CD3/CD28-activated CD4+ T cells or nonstimulated (quiescent) CD4+ T cells were
infected with wild-type (WT) or DNef HIV-1 variants or were left uninfected (mock). Cultures were monitored for viral replication (reverse transcriptase activity in
culture supernatants; left panel) and for ferritin release (right panel).
(H) HIV-1-infectedmacrophages do not release ferritin in response to paracrine factors. Supernatants from wild-type and DNef HIV-1 infected, mock-infected. or
TNFa-treated macrophages were added to fresh uninfected macrophages in the presence and absence of AZT (to prevent de novo infection by viruses in culture
supernatants), and ferritin release was evaluated after 4 or 24 hr (values represent mean ± SD of two independent experiments performed in duplicate).with this, mRNAs for IkBa and NF-kB-p105, the precursor of the
NF-kB p50 subunit and cytoplasmic anchor, were induced in
wild-type HIV-1-infected macrophages relative to HIV-1DNEF or
mock-infected macrophages (Figures 3A and 3B) (also exam-
ined at the peak of HIV-1 replication). In addition, when HIV-
1-infected macrophages were examined at the peak of HIV-1
replication (Figure 3C), IkBa was phosphorylated on a specific
regulatory serine residue (S32), demonstrating NF-kB activation
in HIV-1WT-infected macrophages relative to HIV-1 DNef-
infected or mock-infected macrophages (Figure 3D). These
effects were recapitulated in macrophages expressing Nef.
Therefore, there was increased turnover of mRNAs encoding
IkBa and NF-kB-p105 in macrophages expressing Nef consis-
tent with activation of NF-kB (Figure 3E). This was further
evidenced in immunoprecipitation/in vitro kinase assays of up-
stream IKKa/b using recombinant IkBa as substrate, where Nef66 Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc.induced a strong activation of the IKK kinases in line with that
seen with TNFa treatment (Figure 2F). To determine whether
the induction of ferritin was NF-kB dependent, macrophages
were coinfected with adenoviruses expressing Nef and a domi-
nant negative form of IkBa (IkBaSR) (Brown et al., 1995). Since
the efficiency of adenoviral transduction was equivalent when
macrophages were infected with the adenovirus vectors singly
or in combination (data not shown), coinfection experiments
were performed. In the presence of the IkBaSR suppressor,
the induction of ferritin by Nef was reduced to background
(mock) levels (Figure 3G), whereas ferritin production was unaf-
fected by coinfection with an adenovirus vector expressing
lacZ (Figure 3G). The ability of the IkBaSR to inhibit Nef-medi-
ated ferritin induction was not due to effects of this suppressor
onNef expression since levels of Nef were similar in the presence
and absence of the IkBaSR (Figure 3H). In addition, the IkBaSR
Cell Host & Microbe
Nef-Induced B Cell Dysfunction in HIV InfectionFigure 3. HIV-1 Nef Induces Ferritin Production by Macrophages through an NF-kB-Dependent Pathway
(A and B) Nef-dependent induction of IkBa (A) and NF-kB-p105 (B) expression in HIV-1-infected macrophages (*).
(C and D) Nef-dependent activation of IkBa. Macrophage lysates obtained at the peak of viral replication (C) were examined bywestern blotting with antibodies to
IkBa (D, lower panel) and with an antibody specific to the active (phosphorylated) form of IkBa (D, upper panel).
(E) HIV-1 Nef expression in macrophages is sufficient for induction of IkBa and NF-kB-p105 induction in macrophages. Quantitative RT-PCR was performed
approximately 16 hr posttransduction with adenovirus vectors expressing Nef or GFP. Nontransduced (mock) macrophages served as a control (*).
(F) Specific activation of IkBa activating kinases IKKa/b in macrophages expressing HIV-1 Nef. IKKa/b levels were determined by 32P-in vitro kinase assay and
densitometry.
(G) Ferritin induction by HIV-1 Nef is blocked by a specific inhibitor of IkBa phosphorylation. Macrophages were infected singly or coinfected with the indicated
adenovirus vectors and assayed for ferritin after 16 hr. IkBaSR is a dominant-negative variant of IkBa containing serine-to-alanine mutations at positions 32 and
36 that prevent IkBa phosphorylation and subsequent degradation (**).
(H) Expression of Nef itself was not impacted by the presence of the dominant negative IkBa.
(I) Inhibition of CD40-dependent chemokine production (MIP-1a) by IkBaSR (**).
(J) HIV-1 Nef is sufficient to upregulate ferritin mRNAs in macrophages. Real-time PCR analysis using primers specific to either FTL or FTH subunits was per-
formed on RNA from macrophages transduced with adenovirus vectors expressing Nef, GFP, or on RNA from mock-infected or TNFa-stimulated macrophages
(**). Where indicated by *, panels show representative data from two independent experiments. Where indicated by **, values represent mean ± SD of two
independent experiments performed in duplicate.impaired CD40-dependent chemokine induction in primarymac-
rophages (Figure 3I), consistent with our previous observations
(Swingler et al., 2003). The ability of the IkBaSR to almost
completely negate the ability of Nef to induce ferritin suggests
a principal role for the canonical NF-kB pathway in the induction
of ferritin by Nef. Proinflammatory signals have been shown to
directly regulate ferritin at the transcriptional level. Likewise,
both Nef expression and TNFa substantially increased the level
of mRNA for both ferritin light chain and ferritin heavy chain(Figure 2J). These results suggest that Nef exerts a direct effect
on ferritin transcription more similar to a proinflammatory stimu-
lus than the enhancement of mRNA translation mediated by iron
regulatory proteins (Fahmy and Young, 1993; Pham et al., 2004).
Ferritin Drives B Cell Proliferation
and Immunoglobulin Synthesis
To determine whether the effects of Nef on B cell function
were mediated by ferritin, we examined the impact of ferritinCell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 67
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immunoglobulin secretion by Nef-expressing macrophage su-
pernatants. Ferritin was quantitatively removed by immunode-
pletion with a ferritin-specific antibody but not with an isotype
antibody (Figure 4A). While Nef-expressing macrophage super-
natants immunodepleted with an isotype antibody-induced
B cell proliferation, B cell proliferation was reduced to back-
ground (GFP-expressing) levels when ferritin was immunode-
pleted (Figure 4A). Similarly, supernatants of Nef-expressing
macrophages did not induce immunoglobulin secretion from
B cells when ferritin was removed from these supernatants
(Figure 4B). Previous studies have indicated that recombinant
Nef protein can induce the release of inflammatory factors
from macrophages and suppress class switching in B cells
(Mangino et al., 2007; Olivetta et al., 2003; Qiao et al., 2006).
Therefore, one possibility is that extracellular Nef released from
transduced macrophages were mediating the effects of these
macrophage supernatants. However, immunodepletion of Nef
from supernatants of Nef-transduced macrophages had no ef-
fect on the ability of these supernatants to induce B cell prolifer-
ation (Figure 4C). Since the effects of recombinant Nef were
observed at high concentrations of the protein, it was possible
that supernatants of Nef-transduced macrophages contain
insufficient quantities of Nef to effect B cell function. However,
recombinant Nef at concentrations up to 1,000 ng/ml did not
induce B cell proliferation (Figure 4D). This suggests that the
induction of B cell proliferation and immunoglobulin release by
Nef-expressing macrophage supernatants occurs due to virus
infection and the de novo expression of Nef.
To determine if B cell differentiation and immunoglobulin re-
lease could be recapitulated by ferritin alone, purified human
liver ferritin (PF), consisting of broadly equivalent amounts of
heavy and light chains (data not shown), recombinant light chain
ferritin (FTL), and recombinant heavy chain ferritin (FTH),
were examined for their ability to induce B cell proliferation.
At concentrations observed in macrophage supernatants
(200 ng/ml), all ferritins produced significant B lymphocyte prolif-
eration when compared to a potent activation stimulus (aIgD/
IL-4/rCD40L) (Figure 5A). Since PF was most representative of
Nef-induced, macrophage-derived ferritin, its ability to induce
B cell activation and differentiation was further studied by flow
cytometry. PF stimulation caused an increase in expression of
the markers CD38 and CD70 on populations of B cells
(Figure 5B), and surface IgM+ B cells coexpressing the plasma
cell marker CD138 were evident consistently 2 days later on
CD38+ B cells (Figure 5C). Consequently, we next examined
whether PF, FTL, or FTH could induce immunoglobulin secre-
tion. We observed a dose-dependent increase in the production
of IgA, IgG, and IgM following addition of each of the three
ferritins to resting B cells (Figure 5D).
Appropriate signaling through the B cell receptor promotes
B cell proliferation and differentiation via activation of cell-cycle
promoting, antiapoptotic genes (Niiro and Clark, 2002), and
changes in cellular immunology. We compared the expression
of host genes involved in the signal transduction, transcription,
B cell activation, and differentiation by targeted gene arrays on
resting B cells and those stimulated with PF or the B cell stimu-
lus, aIgD/IL-4/rCD40L. The responses of resting B cells to PF
and the B cell differentiation stimulus were highly comparable68 Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc.and revealed an activation of the MAPK and NF-kB pathways
(Figures 5E and 5F). The ability of ferritin to induce B cell prolifer-
ation was significantly impaired in the presence of the NF-kB
inhibitor caffeic acid phenethyl ester (CAPE) and an inhibitor of
MEK-dependent ERK activation (PD98059) (Figure 5G), suggest-
ing that ferritin mediated its effect on B cell function via the
NF-kB and MEK/ERK pathways. B cells exposed to either PF
or aIgD/IL-4/rCD40L showed elevated expression of mRNAs
for activation antigens, plasma cell marker CD138, and immuno-
globulin genes (Figure 5H). In contrast, analysis of mRNAs
encoding an array of transcription factors suggested some dif-
ferences in transcription profiles in B cells stimulated by PF as
opposed to aIgD/IL-4/rCD40L (Figures 5E and 5H). Collectively,
these results indicate that ferritin promotes changes in B cell
gene expression that are mostly reminiscent of those elicited
by a classical B cell stimulus.
Plasma Ferritin Levels Are Statistically Linked
with Hypergammaglobulinemia and Viral Load
In order to evaluate whether ferritin plays a role in B cell dysfunc-
tion during HIV-1 infection, we examined whether there was
a correlation between plasma ferritin concentration, plasma viral
RNA load, and immunoglobulin levels in a cohort of 83 HIV-1-
infected individuals possessing a wide variation in viral load.
As suggested by a previous study where the reduction in patient
viral load due to the application of highly active antiretroviral ther-
apy (HAART) resulted in a corresponding decrease in plasma fer-
ritin levels (Boom et al., 2007), we observed a similar relationship
between viral RNA and ferritin in HIV-1-infected patients
(Figure 6A). Here, a statistically significant relationship was evi-
dent between viral load and plasma ferritin (p < 0.0001), with
a strong degree of correlation between the two parameters (r =
0.79) (Figure 6A). There was also a statistically significant corre-
lation between plasma viral RNA load and hypergammaglobuli-
nemia in HIV-1-infected individuals, with plasma IgA (p <
0.0001; r = 0.70), IgG (p < 0.0001; r = 0.84), and IgM levels (p <
0.0001; r = 0.73) exhibiting a significant and strong relationship
to the extent of viral burden (Figure 6A). Our data also demon-
strated that a highly significant correlation existed between
plasma ferritin and the levels of IgA, IgG, and IgM in HIV-1-
infected patients (Figure 6B). There was a strong relationship
between plasma ferritin and plasma IgA (p < 0.0001; r = 0.48),
plasma ferritin and plasma IgG (p < 0.0001; r = 0.54), and plasma
ferritin and IgM (p < 0.0001; r = 0.57) (Figure 6B). This indicated
that the extent of viral replication, and hence ferritin, in HIV-1-
infected patients was intrinsically linked to the genesis of hyper-
gammaglobulinemia in agreement with our in vitro findings. In
contrast, no correlation was observed between plasma viral
RNA levels and cytokines known to affect B cell function includ-
ing BLyS (B lymphocyte stimulator) or granulocyte-colony
stimulating factor (data not shown).
Ferritin is an acute-phase reactant and is elevated as a conse-
quence of inflammatory disease, infection, and certain neo-
plasms (Olive and Junca, 1996). Other than the cellular activation
evident in HIV-infected macrophages that results in the aberrant
production of ferritin (Figure 2), there was no correlation between
plasma ferritin levels in a cohort of infected patients and sys-
temic immune activation as evidenced by examination of plasma
levels of soluble TNF receptor II (sTNFRII) (p = 0.4911; r = 0.12) or
Cell Host & Microbe
Nef-Induced B Cell Dysfunction in HIV InfectionFigure 4. B Cell Proliferation and Immunoglobulin Production by Supernatants from Nef-Expressing Macrophages Require the Presence of
Ferritin
(A) B cell proliferation depends on the presence of ferritin. Supernatants from macrophages expressing HIV-1 Nef, GFP, or untreated macrophages were immu-
nodepleted with ferritin-specific or isotype antibodies (left-hand panel) and then examined for induction of proliferation in cultures of purified B cells (right-hand
panel).
(B) Ferritin induces the production of immunoglobulin from B cells. Supernatants from Nef-expressing, GFP-expressing, or mock-treated macrophages were
immunodepleted by ferritin-specific or isotype antibodies as in (A). They were assayed for the efficiency of ferritin immunodepletion (left-hand panel) and for their
ability to induce immunoglobulin production from purified B cells (right-hand panels).
(C) Nef immunodepletion does not impact B cell stimulation by supernatants of Nef-expressing macrophages. Supernatants of Nef or GFP-expressing macro-
phages or mock-infected macrophages were treated with three Nef monoclonal antibodies or isotype controls and assayed for their ability to induce B cell
proliferation.
(D) Supernatants from macrophages treated with recombinant HIV-1 Nef or MA proteins do not induce B cell proliferation. Macrophages were treated with the
recombinant proteins over a 6 log range and subsequently assessed for ability to induce B cell proliferation. Panels show representative data from two indepen-
dent experiments, and values represent mean ± SD from duplicates.Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 69
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Nef-Induced B Cell Dysfunction in HIV Infectionb-2 microglobulin (p = 0.2395; r = 0.01) (Figure 6C). To further
confirm the relationship of HIV infection with hyperferritinemia
and hypergammaglobulinemia, ferritin and immunoglobulin
levels were determined in patients with similar viral loads
(104–105 copies per ml) versus normal healthy control subjects
(Figure 6D). HIV-infected individuals demonstrated a statistically
significant elevation of plasma ferritin (p = 0.0019), plasma IgA
(p= 0.0037), plasma IgG (p= 0.0432), and plasma IgM (p= 0.0026)
(Figure 6D). Collectively, this indicates that ferritin is a correlate
of viral RNA and hypergammaglobulinemia but not of immune
activation in HIV-1-infected individuals.
Nef Expression Is Sufficient for the Induction of Ferritin
and Hypergammaglobulinemia In Vivo
We next examined the role of HIV-1 Nef to directly induce the
production of ferritin and associated B cell defects in the
CD4C/HIVNef transgenic murine model of AIDS, where only Nef
among the genes of HIV-1 is expressed in mature and immature
CD4+ T cells and in cells of the myeloid lineage, including mac-
rophages (Hanna et al., 1998). The ability of HIV-1 Nef to induce
ferritin production in mouse cells was first confirmed by transient
transfection of the murine macrophage cell line RAW 264.7. In
these cells, Nef promoted the release of high levels of ferritin
(Figure 7A), and there was a statistically significant relationship
between the introduction of Nef and ferritin (p < 0.0001; n = 12)
(Figure 7B). In serum samples derived from CD4C/HIVNef trans-
genic mice, a significant hypergammaglobulinemia (IgA [p =
0.0147], IgG [p = 0.0068], and IgM [p = 0.0115]) relative to that
in their normal control non-Tg littermates (n = 20) could be de-
tected (Figure 7C), a result consistent with previous results
(Hanna et al., 1998). In addition, these Tg mice showed en-
hanced ferritin levels (p = 0.0003) in their serum, to an extent sim-
ilar to HIV-infected patients (Figure 7C). However, Tg serum
sTNFRII levels showed no indication of systemic immune activa-
tion (data not shown). Although Nef is expressed in both CD4+
T cells and macrophages in these transgenic animals, HIV-1 in-
fection with macrophages—but not T cells—led to induction of
ferritin (Figure 2G). This suggests that macrophages are the prin-
cipal source of ferritin in Nef-transgenic mice. Thus, the Nef-dependent release of ferritin from macrophages in vitro relates
directly to the occurrence of increased circulating ferritin and
immunoglobulin levels in vivo and requires only the Nef gene of
HIV-1.
DISCUSSION
Our studies reveal a pathogenicity determinant within Nef that is
responsible for a central feature of HIV-1 immunopathogenicity.
The inappropriate activation and differentiation of B cells during
HIV-1 infection impairs the development and maintenance of
a normal humoral immune response (De Milito et al., 2004b).
While the mechanisms responsible for collateral B cell dysfunc-
tion are complex, soluble factors regulated by Nef in HIV-1-
infected macrophages are a significant factor. Elevated ferritin
levels in HIV-1 infection have been reported (Gordeuk et al.,
2001) but the pathophysiological relevance of this has not previ-
ously been ascertained. We report that HIV-1-infected macro-
phages release ferritin due to Nef expression and that this
induced the proliferation of resting B lymphocytes and their dif-
ferentiation into immunoglobulin-producing plasma cells. The
accessory protein Nef is necessary for viral replication in vivo
and has a role in subverting the humoral immune response. We
present evidence that Nef activates ferritin production in macro-
phages via the NF-kBpathway.Motifs in Nef that are responsible
for NF-kB activation remain to be identified. Previous studies
show thatmyristoylation and proline-repeat mutants of Nef failed
to potentiate T cell receptor activation and subsequent NF-kB
signaling because they were mislocalized in the cell (Fenard
et al., 2005). In addition, studies have suggested that EE155
and DD174 motifs in Nef were required for the ability of
extracellular recombinant Nef to activate NF-kB inmacrophages
(Mangino et al., 2007; Olivetta et al., 2003). However, Nef-
deletionmutants lacking thesemotifs were still capable of induc-
ing chemokines in HIV-1-infectedmacrophages (L. Dai andM.S.,
unpublished data). Since we have previously demonstrated that
chemokine induction by Nef is NF-kB dependent (Swingler et al.,
2003), these domains may be dispensable for NF-kB activation
in the context of Nef synthesized de novo during viral infectionFigure 5. Recombinant or Purified Natural Ferritins Fully Recapitulate the B cell Stimulatory Activities of Ferritin Present in Supernatants of
Macrophages Infected with HIV-1 or from Those Expressing Nef
(A) Induction of B cell differentiation and immunoglobulin production by FTL, FTH, and PF. Purified B cells were incubated with 200 ng/ml of each ferritin (equiv-
alent to the concentration induced by Nef-expressing supernatants), and cellular proliferation was assessed by thymidine incorporation.
(B and C) Purified ferritin promotes differentiation of B lymphocytes. B cells were incubated with ferritin (200 ng/ml) as in (A), and flow-cytometric analyses were
performed for CD19, CD38, and CD70 expression at 5 days (B) and for CD138 and sIgM antigens at 7 days postexposure (C). Percent-positive cells are shown in
bar charts for (B) (error bars, SD) and in each quadrant of scatterplots for CD38+-gated B cells (C).
(D) Ferritin alone is sufficient to drive immunoglobulin production from purified B cells. Increasing concentrations of FTL, FTH, or PF were incubated with cultures
of B cells and examined for immunoglobulin production at 7 days postexposure.
(E) Induction of ERK and NF-kB pathways in B cells by purified ferritin. Fold increases in mRNA levels in B cells treated with purified ferritin (PF), mock-treated B
cells, or B cells subjected to an activation stimulus (aIgD/IL-4/rCD40L) are shown relative to levels in untreated (mock) B cells. Fold changes >1.73 are considered
significantly different (Butte et al., 2001).
(F) Activation of NF-kB and ERK pathways in B cells by PF. Lysates of B cells treated with PF or a B cell activation stimulus (aIgD/IL-4/rCD40L) were western
blotted with IkBa-specific antibodies or antibodies specific for active (phosphorylated) IkBa. ERK3 activation was assessed by ability of ERK3 immunoprecip-
itates to induce phosphorylation of myelin basic protein (MBP) in an in vitro kinase assay.
(G) The effect of NF-kB andMEK inhibitors on B cell activation by ferritin. B cells were subjected to the indicated stimuli in the presence and absence of the NF-kB
inhibitor CAPE (5 mg/ml) or the MEK inhibitor PD98059 (10 mM).
(H) Comparative analysis of expression profiles of genes involved in transcription, B cell activation/proliferation and differentiation to immunoglobulin-secreting
plasma cells in B cells treated with purified ferritin, and untreated cells or B cells exposed to an activation stimulus (aIgD/IL-4/rCD40L). Results are calculated as
fold increases in mRNA levels relative tomock-treated B cells. Panels show representative data from two independent experiments, and values represent mean ±
SD from duplicates were present in figure.Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 71
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Nef-Induced B Cell Dysfunction in HIV InfectionFigure 6. In a Cohort of HIV-1-Infected Patients, vRNA Load Correlates with Ferritin, IgA, IgG, and IgM Levels in Plasma
(A) Correlation between plasma HIV-1 RNA, immunoglobulin, and ferritin levels in HIV-1-infected individuals (n = 83) was examined by linear regression analysis,
where p indicates the significance of the relationship and r indicates the strength of the association between the parameters. Best-fit lines are indicated in red, and
gray-dashed lines show the 95% confidence limits.
(B) Ferritin and IgA, IgG, and IgM levels correlate in HIV-1-infected individuals.
(C) No significant relationship occurs between ferritin and plasma levels of the immune activation markers sTNFRII (left panel) and b-2 microglobulin (right panel).
Scatterplots and statistical analyses for (B) and (C) were performed as in (A).
(D) Analysis of HIV-1-infected and -uninfected individuals demonstrates HIV-dependent hyperferritinemia and hypergammaglobulinemia (t test; error bars, SEM).of macrophage. Preliminary analysis indicates that the ability of
Nef to activate NF-kB signaling can genetically be uncoupled
from other reported activities of Nef including CD4 and MHC-I
downregulation (L. Dai and M.S., unpublished data).
Previous reports indicate that ferritins have immunomodula-
tory functions that extend beyond their accepted role in iron me-
tabolism. Ferritin promotes the growth of B leukemic cell lines
(Kikyo et al., 1995 and S.S. and M.S., unpublished data). Modifi-
cation of ferritin levels in HeLa cells by RNA interference does not
influence iron availability but positively affected cell proliferation
rate in an iron-independent manner (Cozzi et al., 2004). Ferritin-
binding activity has been observed on a variety of cell types, in-
cluding B cells and T cells (Anderson et al., 1989; Fargion et al.,
1991) but the identity of the receptor for ferritin is unclear, as well
as proximal membrane events that accompany ferritin binding.
However, recently it has become evident that ferritin cooperates
with a number of known cellular receptors for G-CSF and SDF-1
(Li et al., 2006; Yuan et al., 2004). The interaction of ferritin with
G-CSF-R transduces a signal and likely explains the previously72 Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc.described importance of ferritin inmyelopoesis, whereas binding
of ferritin to CXCR4 modulated chemokine-receptor signaling
and chemotaxis (Li et al., 2006). These observations underscore
the emerging importance of ferritins in regulating lymphocyte
function. Our studies indicate that ferritins induced by HIV-1
Nef account for B cell abnormalities observed in HIV-1 infection.
In the context of viral infection, another study has demonstrated
that HIV-1 Nef manipulates cellular iron homeostasis by downre-
gulating the hemochromatosis protein (HFE) (Drakesmith et al.,
2005). As a result, Nef-induced, HFE-dependent ferritin iron
accumulation in macrophages, which has also been previously
reported in HIV-1-infected microglia (Yoshioka et al., 1992), is
consistent with our study demonstrating that ferritin is a target
of HIV-1 Nef. Modulation of HFE also likely serves to aid virus-
infectedcells evading immune recognition through theassociated
downregulationof class IMHC.Thus, ferritin inductionbyNefmay
contribute to a comprehensive strategy enabling enhanced viral
growth and persistence in the face of a hostile immune environ-
ment (Ben-Arieh et al., 2001; Drakesmith et al., 2005).
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Nef-Induced B Cell Dysfunction in HIV InfectionFigure 7. HIV-1 Nef Induces Ferritin Release from theMurine Macrophages andMice Transgenic for HIV-1 Nef Exhibit Hyperferritinemia and
Hypergammaglobulinemia
(A) The murine macrophage cell line RAW 264.7 was transiently transfected with plasmids expressing HIV-1 Nef, CAT, mock-treated, or stimulated with
IFNg/LPS, and ferritin levels in supernatants were measured after 16 hr.
(B) Statistical analysis of ferritin release from murine macrophage cell cultures expressing HIV-1 Nef, CAT, mock-treated, or stimulated with IFNg/LPS (ANOVA;
error bars, SEM).
(C) Analysis of HIV-1 Nef transgenic mice and control non-Tg litter mates demonstrates statistically significant Nef-dependent increases in serum ferritin and
immunoglobulins, IgA, IgG, and IgM (t test; error bars, SEM).Ferritin—whether derived from Nef-expressing macrophages,
HIV-1-infected macrophages, or in purified and recombinant
form—was sufficient to induce a pattern of B cell hyperactivation
and elevated immunoglobulin synthesis mirroring B cell dysfunc-
tion observed in vivo (Conge et al., 1998; De Milito, 2004a,
2004b). In vitro, ferritin alone recapitulated the activated pheno-
type of B lymphocytes derived from HIV-infected patients. This
was evident by upregulation of the activation marker CD38
(Conge et al., 1998); the expression of CD70, which has been
shown to be aberrantly displayed by naive B cells from HIV-
infected individuals (De Milito, 2004a); and the increase in
CD138+ immunoglobulin-secreting plasma cells. The antigen
nonspecific activation of resting B cells by ferritin released by
infected macrophages is likely a consequence of chronic HIV
infection and immune activation. In this scenario, persistent an-
tigen exposure depletes the memory B cell pool and leads to the
development of naive, activated B lymphocytes that undergo
activation and differentiation in response to abnormal stimuli
(De Milito, 2004a). Such a hypothesis was supported from
flow-cytometry analyses, which indicated that immunoglobu-
lin-secreting CD138+ cells remained highly CD19 positive (data
not shown).
The positive correlations between plasma viral RNA load, fer-
ritin, and immunoglobulin levels seen in HIV-1-infected individ-
uals were similarly found in mice transgenic for HIV-1 Nef and
paralleled the ability of Nef to induce ferritin from macrophage
cultures in vitro. Both HIV-infected patients and mice transgenic
for Nef exhibit B cell dysfunction. These results suggest that the
elevated levels of ferritin in HIV-1-infected individuals are a direct
result of viral replication and resultant Nef expression. Further-
more, the observation that ferritin correlated strongly with
plasma viral RNA and immunoglobulin levels but not with
markers of immune activation (sTNFRII; b-2 microglobulin) or
markers of immune function, such as neopterin and serum albu-
min (data not shown), indicated that hyperferritinemia was not
a consequence of generalized immune activation. In HIV-1-in-
fected individuals, elevated ferritin production may be restricted
to the lymphoid tissues where HIV-1-infected macrophages are
abundant (Embretson et al., 1993). In HIV-1-infected individuals,intestinal mucosa, which is a major reservoir of infected macro-
phages, contains 100-fold higher frequencies of antibody-
secreting cells than blood (Eriksson et al., 1995). Therefore, B
cells within the lymphoid tissue may be predisposed to the local-
ized effects of soluble factors that are released from infected
macrophages.
We have previously shown that HIV-1 Nef intersects the CD40-
signaling pathway in macrophages and, as a result, induces the
release of soluble factors that enhance susceptibility of CD4+ T
cells to HIV-1 infection (Swingler et al., 2003). These soluble pro-
teins do not act directly on T cells. Rather, they stimulate the
expression of costimulatory molecules on B cells that, in turn,
engage corresponding ligands on T cells and render them per-
missive to HIV-1 infection (Swingler et al., 2003). The impact of
Nef on T cell permissivity is mechanistically distinct from its ef-
fect on ferritin production and B cell proliferation. Nef intersects
the CD40-signaling pathway in order to affect T cell permissivity
(Swingler et al., 2003). However, we observed that induction of
ferritin by Nef was CD40 independent, and immunodepletion of
ferritin from Nef-expressing macrophage supernatants did not
affect the ability of those supernatants to promote T cell permis-
sivity (data not shown). Thus, Nef induces the release of soluble
factors frommacrophages that both promote conditions for viral
spread (in the case of T cell permissivity) and drive dysfunction in
the humoral immune system (in the case of B cell activation).
EXPERIMENTAL PROCEDURES
Cells and Viruses
Lymphocytes and monocytes were obtained by leukapheresis from normal
donors seronegative for HIV-1 and hepatitis B. Populations of T and B lympho-
cytes were obtained by additional purification with antibody-coated magnetic
beads (Dynal-Invitrogen, Carlsbad, CA) according to manufacturer’s instruc-
tions.Cell puritywasdeterminedby flow-cytometric stainingwith fluorochrome
antibodies toCD3 (T cell), CD19 (B cell), andCD45 (leukocyte) (BDPharMingen,
San Diego, CA). Monocytes were further separated by countercurrent centrif-
ugal elutriation (Gendelman et al., 1988), and elutriated monocytes differenti-
ated to macrophages by culture for 4 days in medium containing 1000 U/ml
M-CSF (R&D Systems, Minneapolis, MN) and for a further 3 days in medium
lacking M-CSF. Macrophages were then used for virus infections within 1–5
days. R5-tropic HIV-1ADA viruses were prepared by transient transfection ofCell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc. 73
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say (Swingler et al., 1999). The production of recombinant adenoviruses, trans-
duction of macrophages, and the preparation of macrophage supernatants
and immunedepletion have been described previously (Swingler et al., 1999).
Reagents and ELISA
FTL, FHL, PF, CAPE, and PD98059were obtained fromCalbiochem (EMDBio-
sciences, La Jolla, CA). Recombinant human IL-4, TNFa, andmurine IFNgwere
supplied by R&D Systems (Minneapolis, MN) and human recombinant soluble
CD40L by Alexis Corporation (San Diego, CA). Recombinant human IkBa was
from Santa Cruz Biotechnology (Santa Cruz, CA), and recombinant Nef was
supplied by Immunodiagnostics (Woburn, MA). Antigen-capture ELISAs for
ferritin and immunoglobulins were constructed with antibody-coated plates,
and HRP-conjugated secondary antibody-specific antibodies were obtained
from Dako Corporation (Carpintera, CA), MP Biologicals (Solon, OH), and Fitz-
gerald Industries International, Inc. (Concord, MA). Antibodies specific to hu-
man and murine immunoglobulin subtypes IgD, IgA, IgG, IgM, control normal
immunoglobulins, and LPS were obtained from Sigma (St. Louis, MO). ELISA
kits for human andmurine soluble TNFRII and b-2 microglobulin were supplied
by R&D Systems. ELISA kits specific for murine ferritin were from Panapharm
Laboratories (Kunamoto, Japan). Antibodies to IKKa and IKKb were obtained
from Santa Cruz Biotechnology. Western blotting and immunodepletion of
HIV-1 Nef antibodies were purchased from ABI (Foster City, CA).
Lymphocyte Assays
For induction of lymphocyte DNA synthesis, T or B cells were incubated with
macrophage supernatants or ferritins for 3 days, and DNA synthesis (3H-thymi-
dine incorporation) was measured 16 hr after the addition of 1 m Ci 3H-thymi-
dine. At 5 and 7 days poststimulation, B cell differentiation to plasma cells was
analyzed by flow cytometry using fluorochrome-conjugated antibodies (BD
PharMingen) to CD19, CD38, CD70, or surface IgM and CD138, respectively.
Secretion of immunoglobulins in cell supernatants was determined at the
same time by ELISA. For both assays, B cells stimulated for 16 hr with Anti-
IgD (25 mg/ml), IL-4 (5 ng/ml), and rCD40L (10 ng/ml) served as a positive
control. To assess the effects of HIV-1 Nef-expressing or HIV-1-infected mac-
rophage supernatants on B cell differentiation, purified B cells were incubated
with macrophage supernatants and flow-cytometric analysis for CD19, CD38,
and CD70 expression was performed after 5 days while CD138 and sIgMwere
analyzed after 7 days. FACS scatterplots of CD138 and sIgM expression were
performed on CD38+-gated B cells. Supernatants from HIV-1-infected macro-
phages were obtained at the peak of viral replication as measured by reverse
transcriptase activity in culture supernatants.
Identification of Ferritin in Macrophage Supernatants
The molecular weight of the B cell stimulatory activity released from macro-
phages in response to Nef expression was determined by separation through
Centricon filters (Millipore, Billerica, MA) of increasing molecular size. Subse-
quently, serum-free supernatant (50 ml) from adenovirus-transduced macro-
phages was concentrated 250-fold by centrifugation through a series of
100 kD NMWL Centricon filters and resolved by gel electrophoresis. Following
staining with Coomassie blue, candidate protein bands were excised, di-
gested with trypsin, and subjected to microsequencing and mass spectros-
copy as detailed elsewhere (Guilherme et al., 2000). Western blotting was per-
formed with antibodies reactive to human ferritin (MP Biologicals, Solon, OH).
In earlier experiments, serum-free supernatants derived from macrophages
expressing Nef of control GFP 16 hr after adenoviral transduction were
concentrated approximately 250-fold by centrifugation through 10 kD
NMWLCentricon filters and resolved by nondenaturing protein gel electropho-
resis. Protein was determined by comigration of nondenatured molecular
weight markers and Coomassie blue staining of a parallel gel. Following elec-
trophoresis, equal 1 cm slices of the gel were excised and proteins eluted in
0.5 ml Tris-buffered saline and agitated overnight at 4C. Eluates were subse-
quently sterilized by filtration, and the approximate molecular weight of the B
cell stimulatory activity was determined as described in lymphocyte assays.
RNA Analysis
The levels of mRNAs were assessed on total RNA from 1.4 3 106 macro-
phages 4 hr following adenoviral transduction or TNFa stimulation (2 hr after74 Cell Host & Microbe 4, 63–76, July 17, 2008 ª2008 Elsevier Inc.stimulation with 1000 U/ml TNFa for 2 hr). Total RNA was prepared by Trizol
(Invitrogen, Carlsbad, CA) and analyzed by SyBr Green real-time RT-PCR
(Quantitect SyBr Green Kit; QIAGEN, Valencia, CA) using gene-specific
primers for FTL and FTH. B lymphocyte gene expression was analyzed after
4 days stimulation with ferritin or Anti-IgD/IL-4/rCD40L using pathway- and
cell-specific cDNAmicroarrays (SuperArray, Frederick, MD) as described pre-
viously (Swingler et al., 2003). For ferritin mRNA analysis, quantitative RT-PCR
was performed using the following primers to specifically amplify nucleotide
sequences corresponding to FTL: [s] 50-AGAATTATTCCACCG ACGTGG-30;
[as] 30-GGTAGAGACACTGAAGGACCT-50, and FTH [s] 50-CGACCGCGTCC
ACCTCGCAGG-30; and [as] 30-GGAAGTCCTATAGTTCTTTGG-50.
NF-kB Pathway Activation
To assess NF-kB induction in macrophages, the activity of the upstream
kinases IKKa/b was determined by immunoprecipitation and in vitro assay.
Briefly, 9 3 106 cells transduced with adenoviruses, mock infected, or stimu-
lated with 1000 U/ml TNFa were lysed in RIPA buffer after incubation for 2 hr.
Cellular IKKa/b was precipitated by specific antibodies and immune com-
plexes subject to in vitro kinase assay with 32P-g-ATP and 2.5 mg recombinant
IkBa. Kinase reactions were resolved by SDS-PAGE and proteins transferred
to polyvinylidene difluoride (PVDF) for Phosphor Imaging or western blotting.
For the analysis of ERK3, 5 3 106 B cells stimulated as indicated for 2 hr
were lysed and similarly immunoprecipitated and assayed for kinase activity
with 2.5 mg myelin basic protein (Sigma) as an appropriate substrate. Phos-
phorylation of IkBa on serine 32 was determined by western blotting using
specific antisera from Cell Signaling Technologies (Danvers, MA). The activa-
tion of NF-kB by HIV-1 Nef was further demonstrated by cotransduction of
macrophages with equal amounts of recombinant adenoviruses expressing
a dominant negative IkBk, or a lacZ control. The dominant-negative IkBa pro-
tein contained serine-to-alanine mutations at positions 32 and 36, thus pre-
venting its phosphorylation and subsequent release of NF-kB (Iimuro et al.,
1998). Cellular turnover of mRNAs for IkBa and NF-kB-p105 was performed
as described except analyses were performed using cDNA microgene arrays
(SuperArray) and ribonuclease protection assays (Swingler et al., 2003).
Biological Samples
Blood samples were obtained from HIV-1-positive individuals at the UMass
Memorial Medical Center outpatient clinics. Patient samples were selected
for this study on the basis of providing a broad range of CD4+ T cell counts
(percentage CD4+ = 5%–53%; absolute CD4+ T cell numbers were 20–1660
cell/ml), and plasma viral RNA levels were from <50 to >900,000 copies/ml.
Samples were obtained prior to or during periods of cessation from antiretro-
viral treatment. Informed consent was obtained from all HIV-1 individuals, and
the studies were approved by the UMMS Human Subjects Committee. The
CD4C/HIVMutG (designated here CD4C/HIVNef) Tg mice have been described
previously (Hanna et al., 1998). Serum samples from animals (3–7 months
old) confirmed to be transgenic for Nef, and mates were used for the analysis
of ferritin and immunoglobulin levels from their normal non-Tg control litter.
Biostatistics
The statistical significance of data, where indicated, was determined by
ANOVA or two-tailed t test. Mean values ± SEM are shown graphically, and
annotations indicate the confidence level (p value) and number of replicates
(n). Viral load, ferritin, and immunoglobulin levels were analyzed by linear
regression, where r described the strength of the relationship and two-tailed
t test described significance. In all analyses, p values%0.05 were considered
significant. Statistical calculations were performed using Prism 5 (GraphPad
Software).
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